Raper SE - Search Results

1

Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver.

Bell P, Moscioni AD, McCarter RJ, Wu D, Gao G, Hoang A, Sanmiguel JC, Sun X, Wivel NA, Raper SE, Furth EE, Batshaw ML, Wilson JM. Bell P, et al. Among authors: raper se. Mol Ther. 2006 Jul;14(1):34-44. doi: 10.1016/j.ymthe.2006.03.008. Epub 2006 May 6. Mol Ther. 2006. PMID: 16682254 Free article.

2

A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency.

Raper SE, Yudkoff M, Chirmule N, Gao GP, Nunes F, Haskal ZJ, Furth EE, Propert KJ, Robinson MB, Magosin S, Simoes H, Speicher L, Hughes J, Tazelaar J, Wivel NA, Wilson JM, Batshaw ML. Raper SE, et al. Hum Gene Ther. 2002 Jan 1;13(1):163-75. doi: 10.1089/10430340152712719. Hum Gene Ther. 2002. PMID: 11779420

3

Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors.

Moscioni D, Morizono H, McCarter RJ, Stern A, Cabrera-Luque J, Hoang A, Sanmiguel J, Wu D, Bell P, Gao GP, Raper SE, Wilson JM, Batshaw ML. Moscioni D, et al. Among authors: raper se. Mol Ther. 2006 Jul;14(1):25-33. doi: 10.1016/j.ymthe.2006.03.009. Epub 2006 May 3. Mol Ther. 2006. PMID: 16677864 Free article.

4

Flushing out antibodies to make AAV gene therapy available to more patients.

Raper SE, Wilson JM, Nunes FA. Raper SE, et al. Mol Ther. 2013 Feb;21(2):269-71. doi: 10.1038/mt.2013.5. Mol Ther. 2013. PMID: 23369966 Free PMC article. No abstract available.

5

Gene therapy for human liver disease.

Raper SE, Wilson JM. Raper SE, et al. Prog Liver Dis. 1995;13:201-30. Prog Liver Dis. 1995. PMID: 9224503 Review.

6

Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.

Raper SE, Haskal ZJ, Ye X, Pugh C, Furth EE, Gao GP, Wilson JM. Raper SE, et al. Hum Gene Ther. 1998 Mar 20;9(5):671-9. doi: 10.1089/hum.1998.9.5-671. Hum Gene Ther. 1998. PMID: 9551615

7

Evaluating the potential of germ line transmission after intravenous administration of recombinant adenovirus in the C3H mouse.

Ye X, Gao GP, Pabin C, Raper SE, Wilson JM. Ye X, et al. Among authors: raper se. Hum Gene Ther. 1998 Sep 20;9(14):2135-42. doi: 10.1089/hum.1998.9.14-2135. Hum Gene Ther. 1998. PMID: 9759939

8

Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration.

Nunes FA, Furth EE, Wilson JM, Raper SE. Nunes FA, et al. Among authors: raper se. Hum Gene Ther. 1999 Oct 10;10(15):2515-26. doi: 10.1089/10430349950016852. Hum Gene Ther. 1999. PMID: 10543616

9

Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.

Schnell MA, Zhang Y, Tazelaar J, Gao GP, Yu QC, Qian R, Chen SJ, Varnavski AN, LeClair C, Raper SE, Wilson JM. Schnell MA, et al. Among authors: raper se. Mol Ther. 2001 May;3(5 Pt 1):708-22. doi: 10.1006/mthe.2001.0330. Mol Ther. 2001. PMID: 11356076 Free article.

10

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.

Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, Wilson JM, Batshaw ML. Raper SE, et al. Mol Genet Metab. 2003 Sep-Oct;80(1-2):148-58. doi: 10.1016/j.ymgme.2003.08.016. Mol Genet Metab. 2003. PMID: 14567964 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters